Discontinued — last reported Q4 '25
Tax
Deferred Tax
Biogen Deferred Tax decreased by 90.7% to $23.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 184.9%, from -$27.80M to $23.60M.
Analysis
StatementIncome Statement
SectionTax
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
A large deferred tax benefit may indicate future tax liabilities, while a large expense may suggest future tax savings.
Detailed definition
This metric represents the portion of income tax expense that is deferred to future periods due to temporary differences...
Peer comparison
Standard accounting line item found in the tax reconciliation section of the income statement for most public companies.
Metric ID:
msft_deferred_income_tax_expense_benefitHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$607.80M | -$127.30M | $1.00M | -$48.50M | -$92.30M | -$64.50M | -$106.40M | -$206.80M | $39.90M | -$87.00M | -$52.60M | -$27.80M | -$31.30M | $253.80M | $23.60M |
| QoQ Change | — | +79.1% | +100.8% | <-999% | -90.3% | +30.1% | -65.0% | -94.4% | +119.3% | -318.0% | +39.5% | +47.1% | -12.6% | +910.9% | -90.7% |
| YoY Change | — | — | — | +92.0% | +27.5% | <-999% | -119.4% | -124.1% | +161.9% | +18.2% | +74.6% | -169.7% | +64.0% | +582.5% | +184.9% |
Range-$607.80M – $253.80M
CAGR-60.5%
Avg YoY Growth-479.8%
Median YoY Growth+45.8%
Deferred Tax at Other Companies
Frequently Asked Questions
- What is Biogen's deferred tax?
- Biogen (BIIB) reported deferred tax of $23.60M in Q1 2026.
- How has Biogen's deferred tax changed year-over-year?
- Biogen's deferred tax increased by 184.9% year-over-year, from -$27.80M to $23.60M.
- What does deferred tax mean?
- The portion of tax expense that is not currently payable but will be settled in future periods.